MapLight Therapeutics Inc
MPLT
NASDAQ
Biotechnology
$11.75
USD
+0.17 (+1.47%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $519.09M
Volume 451.5K
Price Target
$21.00 – $48.00
USD
The 7 analysts offering 1-year price forecasts have a max estimate of $48.00 and a min estimate of $21.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$37.43
-$1.6 vs prior
Implied Upside
+218.6%
-13.4% vs prior
Analyst Covering
7
+4 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
70%
Most ratings are recent - from the last 3 months
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$2.57 Gap
Median $40.00 vs avg $37.43 - a few cautious outliers are pulling the average down
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
6 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
1
Buy
5
Hold
1
Sell
0
Strong Sell
0
7 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Raghuram Selvaraju | HC Wainwright & Co. | Buy | Maintained | 2 weeks ago | Plus | Plus | Plus |
Sean Laaman | Morgan Stanley | Hold | Downgraded | 2 weeks ago | Plus | Plus | Plus |
Ami Fadia | Needham | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Tiago Fauth | Wells Fargo | Strong Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Adam Vogel | Craig-Hallum | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
